Flash Grants infuse funding at a critical early point when a small, targeted influx of funds can be crucial to shaping innovative research ideas into high potential life science technologies, particularly in emerging and converging life science sectors. Up to $20,000 may be requested for short, highly focused projects.
Cycle 3 is a targeted round and is open only to projects in these areas:
-Global Coronavirus disease (COVID-19) outbreak – vaccine development, diagnosis, and COVID-19 specific therapies
-Precision health
-Digital and data-driven life science technologies
Details are in the guidelines, posted at www.ncbiotech.org/flash